CTRB1 and pancreatitis: Inspired by these earlier findings, in the present study we set out to engineer mouse CTRB1 for improved chymotrypsin activity, with the ultimate goal of generating an enzyme capable of rapidly degrading mouse trypsinogens and thereby possessing an enhanced ability to protect against pancreatitis in mouse models.